Fundraising FoxBiodol
Montpellier, FR · 1 known investors
Find your way into Biodol
Sign up to find every way you can get introduced to Biodol
- Your email: who you already know at Biodol, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Biodol team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Biodol Therapeutics is a biotech company developing proprietary FLT3 inhibitors (BDT compounds) at the preclinical stage to treat neuropathic and chronic pain, including opioid-combination indications. It holds a portfolio of patents covering the use of FLT3 inhibitors for pain treatment.
Investors · 1
V-Bio Ventureslisted by V-Bio VenturesGhent · $270K – $2.2M
How we know: funding news · press coverage · Not right? Tell us
Frequently asked questions
- What does Biodol do?
- Biodol Therapeutics is a biotech company developing proprietary FLT3 inhibitors (BDT compounds) at the preclinical stage to treat neuropathic and chronic pain, including opioid-combination indications. It holds a portfolio of patents covering the use of FLT3 inhibitors for pain treatment.
- Who are Biodol's investors?
- Biodol's investors include V-Bio Ventures.
- Where is Biodol headquartered?
- Biodol is headquartered in Montpellier, FR.